Login / Signup

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.

Ting Yi Jessica ChangJanet E Pope
Published in: Immunotherapy (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • juvenile idiopathic arthritis
  • respiratory syndrome coronavirus
  • rheumatoid arthritis